APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Panic Attack Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Panic Attack Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchPanic Attack Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Panic Attack Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Panic Attack Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Panic Attack Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Panic Attack Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Panic Attack Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Panic Attack Treatment include Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Actavis Generics, Bristol Myers Squibb(BMS), Baxter International Inc., Sumitomo Dainippon Pharma, GlaxoSmithKline plc., Pfizer,Inc. and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Panic Attack Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Panic Attack Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Panic Attack Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Panic Attack Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Panic Attack Treatment Segment by Company

Noven Pharmaceuticals, Inc.

Recordati Rare Diseases(Recordati)

Actavis Generics

Bristol Myers Squibb(BMS)

Baxter International Inc.

Sumitomo Dainippon Pharma

GlaxoSmithKline plc.

Pfizer,Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Shionogi & Co., Ltd.

Panic Attack Treatment Segment by Type

Selective Serotonin Reuptake Inhibitor(SSRI)

Benzodiazepines(BZD)

Serotonin Norepinephrine Reuptake Inhibitor(SNRI)

Panic Attack Treatment Segment by Application

Hospitals

Mental Healthcare Centers

Others

Panic Attack Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Panic Attack Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Panic Attack Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Panic Attack Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Panic Attack Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Panic Attack Treatment industry.

Chapter 3: Detailed analysis of Panic Attack Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Panic Attack Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Panic Attack Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Selective Serotonin Reuptake Inhibitor(SSRI) Table 3. Key Players of Benzodiazepines(BZD) Table 4. Key Players of Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Table 4. Global Panic Attack Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Mental Healthcare Centers Table 7. Key Players of Others Table 8. Global Panic Attack Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Panic Attack Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Panic Attack Treatment Market Share by Region (2021-2026) Table 11. Global Panic Attack Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Panic Attack Treatment Market Share by Region (2027-2032) Table 13. Panic Attack Treatment Industry Trends Table 14. Panic Attack Treatment Industry Drivers Table 15. Panic Attack Treatment Industry Opportunities and Challenges Table 16. Panic Attack Treatment Industry Restraints Table 17. Global Panic Attack Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Panic Attack Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Panic Attack Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Panic Attack Treatment Key Company Head Office and Area Served Table 21. Global Panic Attack Treatment Company, Product Type & Application Table 22. Global Panic Attack Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Panic Attack Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Panic Attack Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Panic Attack Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Panic Attack Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Panic Attack Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Panic Attack Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Panic Attack Treatment Revenue Market Share by Application (2027-2032) Table 35. Noven Pharmaceuticals, Inc. Company Information Table 36. Noven Pharmaceuticals, Inc. Business Overview Table 37. Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio Table 39. Noven Pharmaceuticals, Inc. Recent Development Table 40. Recordati Rare Diseases(Recordati) Company Information Table 41. Recordati Rare Diseases(Recordati) Business Overview Table 42. Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio Table 44. Recordati Rare Diseases(Recordati) Recent Development Table 45. Actavis Generics Company Information Table 46. Actavis Generics Business Overview Table 47. Actavis Generics Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Actavis Generics Panic Attack Treatment Product Portfolio Table 49. Actavis Generics Recent Development Table 50. Bristol Myers Squibb(BMS) Company Information Table 51. Bristol Myers Squibb(BMS) Business Overview Table 52. Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio Table 54. Bristol Myers Squibb(BMS) Recent Development Table 55. Baxter International Inc. Company Information Table 56. Baxter International Inc. Business Overview Table 57. Baxter International Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Baxter International Inc. Panic Attack Treatment Product Portfolio Table 59. Baxter International Inc. Recent Development Table 60. Sumitomo Dainippon Pharma Company Information Table 61. Sumitomo Dainippon Pharma Business Overview Table 62. Sumitomo Dainippon Pharma Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio Table 64. Sumitomo Dainippon Pharma Recent Development Table 65. GlaxoSmithKline plc. Company Information Table 66. GlaxoSmithKline plc. Business Overview Table 67. GlaxoSmithKline plc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio Table 69. GlaxoSmithKline plc. Recent Development Table 70. Pfizer,Inc. Company Information Table 71. Pfizer,Inc. Business Overview Table 72. Pfizer,Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pfizer,Inc. Panic Attack Treatment Product Portfolio Table 74. Pfizer,Inc. Recent Development Table 75. Eli Lilly and Company Company Information Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Eli Lilly and Company Panic Attack Treatment Product Portfolio Table 79. Eli Lilly and Company Recent Development Table 80. F. Hoffmann-La Roche Ltd Company Information Table 81. F. Hoffmann-La Roche Ltd Business Overview Table 82. F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio Table 84. F. Hoffmann-La Roche Ltd Recent Development Table 85. Abbott Laboratories Company Information Table 86. Abbott Laboratories Business Overview Table 87. Abbott Laboratories Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Abbott Laboratories Panic Attack Treatment Product Portfolio Table 89. Abbott Laboratories Recent Development Table 90. Shionogi & Co., Ltd. Company Information Table 91. Shionogi & Co., Ltd. Business Overview Table 92. Shionogi & Co., Ltd. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio Table 94. Shionogi & Co., Ltd. Recent Development Table 95. North America Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Panic Attack Treatment Market Size by Country (2021-2026) Table 101. North America Panic Attack Treatment Market Size by Country (2027-2032) Table 102. Europe Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Panic Attack Treatment Market Size by Country (2021-2026) Table 108. Europe Panic Attack Treatment Market Size by Country (2027-2032) Table 109. China Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 110. China Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 111. China Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 112. China Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Panic Attack Treatment Market Size by Country (2021-2026) Table 119. Asia Panic Attack Treatment Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Panic Attack Treatment Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Panic Attack Treatment Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Panic Attack Treatment Product Image Figure 2. Global Panic Attack Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Panic Attack Treatment Market Share by Type: 2025 VS 2032 Figure 4. Selective Serotonin Reuptake Inhibitor(SSRI) Image Figure 5. Benzodiazepines(BZD) Image Figure 6. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Image Figure 7. Global Panic Attack Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Panic Attack Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Mental Healthcare Centers Image Figure 11. Others Image Figure 12. Global Panic Attack Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Panic Attack Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Panic Attack Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Panic Attack Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Panic Attack Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Panic Attack Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Panic Attack Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Panic Attack Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Panic Attack Treatment Market Share by Type (2021-2032) Figure 25. North America Panic Attack Treatment Market Share by Application (2021-2032) Figure 26. North America Panic Attack Treatment Market Share by Country (2021-2032) Figure 27. United States Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Panic Attack Treatment Market Share by Type (2021-2032) Figure 32. Europe Panic Attack Treatment Market Share by Application (2021-2032) Figure 33. Europe Panic Attack Treatment Market Share by Country (2021-2032) Figure 34. Germany Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Panic Attack Treatment Market Share by Type (2021-2032) Figure 42. China Panic Attack Treatment Market Share by Application (2021-2032) Figure 43. Asia Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Panic Attack Treatment Market Share by Type (2021-2032) Figure 45. Asia Panic Attack Treatment Market Share by Application (2021-2032) Figure 46. Asia Panic Attack Treatment Market Share by Country (2021-2032) Figure 47. Japan Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Panic Attack Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Panic Attack Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Panic Attack Treatment Market Share by Country (2021-2032) Figure 57. Brazil Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Selective Serotonin Reuptake Inhibitor(SSRI)
  • Benzodiazepines(BZD)
  • Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Applications
  • Hospitals
  • Mental Healthcare Centers
  • Others
Companies covered
  • Noven Pharmaceuticals, Inc.
  • Recordati Rare Diseases(Recordati)
  • Actavis Generics
  • Bristol Myers Squibb(BMS)
  • Baxter International Inc.
  • Sumitomo Dainippon Pharma
  • GlaxoSmithKline plc.
  • Pfizer,Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Shionogi & Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Panic Attack Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Selective Serotonin Reuptake Inhibitor(SSRI)
  5. 1.2.3 Benzodiazepines(BZD)
  6. 1.2.4 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Panic Attack Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Mental Healthcare Centers
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Panic Attack Treatment Growth Trends by Region
  14. 1.5.1 Global Panic Attack Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Panic Attack Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Panic Attack Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Panic Attack Treatment Market Dynamics
  1. 2.1 Panic Attack Treatment Industry Trends
  2. 2.2 Panic Attack Treatment Industry Drivers
  3. 2.3 Panic Attack Treatment Industry Opportunities and Challenges
  4. 2.4 Panic Attack Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Panic Attack Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Panic Attack Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Panic Attack Treatment Key Company Head office and Area Served
  4. 3.4 Global Panic Attack Treatment Company, Product Type & Application
  5. 3.5 Global Panic Attack Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Panic Attack Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Panic Attack Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Panic Attack Treatment Tier 1, Tier 2, and Tier 3
4 Panic Attack Treatment Market by Type
  1. 4.1 Global Panic Attack Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Panic Attack Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Panic Attack Treatment Market Size Share by Type (2021-2032)
5 Panic Attack Treatment Market by Application
  1. 5.1 Global Panic Attack Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Panic Attack Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Panic Attack Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Noven Pharmaceuticals, Inc.
  2. 6.1.1 Noven Pharmaceuticals, Inc. Company Information
  3. 6.1.2 Noven Pharmaceuticals, Inc. Business Overview
  4. 6.1.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio
  6. 6.1.5 Noven Pharmaceuticals, Inc. Recent Developments
  7. 6.2 Recordati Rare Diseases(Recordati)
  8. 6.2.1 Recordati Rare Diseases(Recordati) Company Information
  9. 6.2.2 Recordati Rare Diseases(Recordati) Business Overview
  10. 6.2.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio
  12. 6.2.5 Recordati Rare Diseases(Recordati) Recent Developments
  13. 6.3 Actavis Generics
  14. 6.3.1 Actavis Generics Company Information
  15. 6.3.2 Actavis Generics Business Overview
  16. 6.3.3 Actavis Generics Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Actavis Generics Panic Attack Treatment Product Portfolio
  18. 6.3.5 Actavis Generics Recent Developments
  19. 6.4 Bristol Myers Squibb(BMS)
  20. 6.4.1 Bristol Myers Squibb(BMS) Company Information
  21. 6.4.2 Bristol Myers Squibb(BMS) Business Overview
  22. 6.4.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio
  24. 6.4.5 Bristol Myers Squibb(BMS) Recent Developments
  25. 6.5 Baxter International Inc.
  26. 6.5.1 Baxter International Inc. Company Information
  27. 6.5.2 Baxter International Inc. Business Overview
  28. 6.5.3 Baxter International Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Baxter International Inc. Panic Attack Treatment Product Portfolio
  30. 6.5.5 Baxter International Inc. Recent Developments
  31. 6.6 Sumitomo Dainippon Pharma
  32. 6.6.1 Sumitomo Dainippon Pharma Company Information
  33. 6.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 6.6.3 Sumitomo Dainippon Pharma Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio
  36. 6.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 6.7 GlaxoSmithKline plc.
  38. 6.7.1 GlaxoSmithKline plc. Company Information
  39. 6.7.2 GlaxoSmithKline plc. Business Overview
  40. 6.7.3 GlaxoSmithKline plc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio
  42. 6.7.5 GlaxoSmithKline plc. Recent Developments
  43. 6.8 Pfizer,Inc.
  44. 6.8.1 Pfizer,Inc. Company Information
  45. 6.8.2 Pfizer,Inc. Business Overview
  46. 6.8.3 Pfizer,Inc. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pfizer,Inc. Panic Attack Treatment Product Portfolio
  48. 6.8.5 Pfizer,Inc. Recent Developments
  49. 6.9 Eli Lilly and Company
  50. 6.9.1 Eli Lilly and Company Company Information
  51. 6.9.2 Eli Lilly and Company Business Overview
  52. 6.9.3 Eli Lilly and Company Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Eli Lilly and Company Panic Attack Treatment Product Portfolio
  54. 6.9.5 Eli Lilly and Company Recent Developments
  55. 6.10 F. Hoffmann-La Roche Ltd
  56. 6.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 6.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 6.10.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio
  60. 6.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 6.11 Abbott Laboratories
  62. 6.11.1 Abbott Laboratories Company Information
  63. 6.11.2 Abbott Laboratories Business Overview
  64. 6.11.3 Abbott Laboratories Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Abbott Laboratories Panic Attack Treatment Product Portfolio
  66. 6.11.5 Abbott Laboratories Recent Developments
  67. 6.12 Shionogi & Co., Ltd.
  68. 6.12.1 Shionogi & Co., Ltd. Company Information
  69. 6.12.2 Shionogi & Co., Ltd. Business Overview
  70. 6.12.3 Shionogi & Co., Ltd. Panic Attack Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio
  72. 6.12.5 Shionogi & Co., Ltd. Recent Developments
7 North America
  1. 7.1 North America Panic Attack Treatment Market Size (2021-2032)
  2. 7.2 North America Panic Attack Treatment Market Size by Type
  3. 7.2.1 North America Panic Attack Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Panic Attack Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Panic Attack Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Panic Attack Treatment Market Size by Application
  7. 7.3.1 North America Panic Attack Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Panic Attack Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Panic Attack Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Panic Attack Treatment Market Size by Country
  11. 7.4.1 North America Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Panic Attack Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Panic Attack Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Panic Attack Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Panic Attack Treatment Market Size (2021-2032)
  2. 8.2 Europe Panic Attack Treatment Market Size by Type
  3. 8.2.1 Europe Panic Attack Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Panic Attack Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Panic Attack Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Panic Attack Treatment Market Size by Application
  7. 8.3.1 Europe Panic Attack Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Panic Attack Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Panic Attack Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Panic Attack Treatment Market Size by Country
  11. 8.4.1 Europe Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Panic Attack Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Panic Attack Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Panic Attack Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Panic Attack Treatment Market Size (2021-2032)
  2. 9.2 China Panic Attack Treatment Market Size by Type
  3. 9.2.1 China Panic Attack Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Panic Attack Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Panic Attack Treatment Market Share by Type (2021-2032)
  6. 9.3 China Panic Attack Treatment Market Size by Application
  7. 9.3.1 China Panic Attack Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Panic Attack Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Panic Attack Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Panic Attack Treatment Market Size (2021-2032)
  2. 10.2 Asia Panic Attack Treatment Market Size by Type
  3. 10.2.1 Asia Panic Attack Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Panic Attack Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Panic Attack Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Panic Attack Treatment Market Size by Application
  7. 10.3.1 Asia Panic Attack Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Panic Attack Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Panic Attack Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Panic Attack Treatment Market Size by Country
  11. 10.4.1 Asia Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Panic Attack Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Panic Attack Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Panic Attack Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Panic Attack Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Panic Attack Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Panic Attack Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Panic Attack Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Panic Attack Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Panic Attack Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Panic Attack Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Panic Attack Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Panic Attack Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Panic Attack Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Panic Attack Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Panic Attack Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst